Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chr. Augustinus Fabrikker is a prominent Danish investment company and the primary asset management arm of the Augustinus Foundation. Established in 1750, the firm has evolved from a tobacco manufacturer into a long-term strategic investor with a significant focus on the life sciences and healthcare sectors. Its portfolio includes substantial ownership stakes in global industry leaders such as Lundbeck, Demant, and Bavarian Nordic. The company operates as an active owner, seeking to generate sustainable returns to support the foundation's philanthropic activities while fostering the growth of Danish business. Its investment strategy encompasses both large-scale listed companies and promising private enterprises across various industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chr. Augustinus Fabrikker.